11/08/2026 10 minutos de leituraPor Rafael

Share:

Index

Sharp-eyed investors have already noticed that AI infrastructure goes far beyond the tech giants dominating the headlines. While the big techs pile up reports of internal burnout, pressure for results, and constant restructuring, a group of smaller and less obvious companies is starting to catch the attention of those watching where AI money actually flows. The promise of effortless productivity that these large companies sell to the market stands in stark contrast to what happens behind the scenes — and it is precisely in that tension where interesting opportunities emerge.

This is not about betting on who will win the AI race, but rather on who supplies the tools that make the race possible. Sensors, power modules, perception platforms, AI-driven biopharmaceutical research — these are the physical backstage of everything you see running. These are the components that keep the big systems up and running, processing data, making decisions, and expanding automation capacity at an industrial scale. And once you understand where the foundation of something as massive as AI actually sits, you start seeing the opportunity map in a completely different way.

Three companies land on the radar here: Ouster (OUST), a specialist in lidar sensors for physical automation; Insmed (INSM), a biopharmaceutical company applying AI to research and protein engineering; and Vicor (VICR), a supplier of high-efficiency power modules for data centers and automation. All of them share something in common: real exposure to AI growth without relying on the internal environment of the major tech corporations. Worth noting that these three are just a sample within a much larger universe of companies tied to this theme — there are dozens of other equally interesting stories waiting to be explored. But heads up: none of them is risk-free, and understanding what is behind each story makes all the difference before any move. 🎯

What ties these three companies together in the AI infrastructure context

When most investors think about AI, the natural path is to go straight for the names everyone already knows — the companies that show up in the news, in analyst reports, and in the portfolios of the most famous funds. But there is a layer beneath that more visible surface, made up of companies that build, power, and enable the operation of the AI systems dominating conversations around the world today. That is the layer where Ouster, Insmed, and Vicor operate, each with its own well-defined niche, but all connected by the same logic: whoever supplies what AI needs to function holds a strategic position that tends to appreciate over time.

This logic is nothing new. It closely mirrors what happened during resource rushes in the past — those who sold the tools often profited more than those chasing the gold. It is the classic strategy of selling the picks and shovels while everyone else digs. In the context of AI infrastructure, the dynamic is similar: large language models, industrial automation systems, and data centers processing billions of requests per day all need hardware, efficient power, and precision sensing. And that is where these three companies show up with concrete offerings — not just as speculative concepts, but as real technology suppliers already serving the market.

Receive the best innovation content in your email.

All the news, tips, trends, and resources you're looking for, delivered to your inbox.

By subscribing to the newsletter, you agree to receive communications from Método Viral. We are committed to always protecting and respecting your privacy.

What makes this group even more interesting for investors looking for diversification within the AI theme is the fact that these companies are not directly exposed to the cultural and organizational pressures of the big techs. They operate in specific niches, with clients who depend on their solutions to keep critical operations running. This creates a technical dependency that, when well established, generates recurring contracts, barriers to entry for competitors, and a stability that does not always show up in the business models of the more visible giants in the sector. 💡

Ouster (OUST): lidar sensors and the future of physical automation

Ouster is a San Francisco-based company that develops lidar sensors — light detection technology — used in applications ranging from autonomous vehicles to industrial robotics, logistics, and traffic infrastructure monitoring. With revenue hovering around $205 million and a market cap of approximately $3.1 billion, the company generates most of its sales in the United States and across the Americas. Lidar works by emitting laser pulses and measuring the time those pulses take to return after hitting an object, creating extremely precise three-dimensional maps of the surrounding environment. This high-fidelity spatial perception capability is exactly what physical automation systems need to operate safely and efficiently in dynamic and unpredictable environments, where conventional cameras or simple radars simply cannot deliver the required precision.

What puts Ouster in a differentiated position within the AI infrastructure conversation is the fact that the company combines sensing hardware with its own software platforms, such as BlueCity, focused on traffic management, and Gemini, focused on perception. This combination gives Ouster a relevant role in smart infrastructure, robotics, and advanced driver assistance systems. Recent collaborations with NVIDIA, heavy equipment manufacturers, and robotics partners show how the company is working to deeply integrate its technology into customer workflows, creating the kind of technical dependency that strengthens market position over the long term.

For investors interested in exposure to AI-enabled physical automation, Ouster represents a bet on sensory infrastructure — the ability of systems to see and interpret the physical world. Without this layer, robots cannot navigate with precision, autonomous vehicles cannot operate safely, and industrial monitoring systems cannot detect anomalies in real time. On the other hand, it is important to be clear-eyed about the risks: the company still operates at a loss, carries financing and share dilution risk, and trades at elevated revenue multiples, which means market expectations are already pretty high. For those who can handle volatility, the combination of automation demand and execution risk makes Ouster a company that many choose to watch closely. 🚀

Insmed (INSM): AI applied to biopharmaceutical research

Insmed operates in a territory that for many might seem far from the tech world, but in practice is increasingly integrated with it: biopharmaceutical research accelerated by artificial intelligence. The company develops and commercializes treatments for serious and rare diseases, including pulmonary infections and complex respiratory conditions, serving both the United States and international markets. With revenue of about $1.1 billion — approximately $969 million from the United States and $169 million from international markets — and a market cap of approximately $28.6 billion, Insmed is the largest of the three companies in terms of capitalization.

What makes Insmed relevant in this context is that its pipeline includes gene therapies and protein engineering projects supported by AI — an area that combines molecular biology with high-performance computing to identify and optimize therapeutic molecules much faster than traditional methods allow. This means the AI infrastructure that Insmed uses is not a cosmetic differentiator, but rather a strategic component of its pursuit of scientific productivity in hard-to-treat medical problems. The company has been leaning into strong respiratory products, like Brinsupri, while simultaneously running multiple late-stage clinical trials.

For investors, Insmed represents a different kind of AI exposure — not through the technology itself, but through the results it enables. The story today revolves around how well the company can build on its respiratory products, execute its late-stage trials, and manage the regulatory and payer hurdles that can affect the timing and adoption of treatments. Analysts have set ambitious price targets, but the risk is real: the company still operates at a loss, has relied heavily on external financing, and has seen recent stock sales by company insiders. For those who can handle clinical and valuation risk, the next few years of launches and trial results will be decisive. 🧬

Vicor (VICR): efficient power as the foundation of AI infrastructure

Vicor is perhaps the least well-known of the three, but it operates at the most fundamental level of AI infrastructure: managing and distributing electrical power within data centers and high-performance computing systems. The company designs and manufactures high-efficiency modular power components that convert and manage electrical power inside complex electronics — from AI chips in data centers to telecom hardware, factory automation, vehicles, and aerospace systems around the world. With revenue of about $474 million — split across the United States (approximately $253 million), Asia-Pacific ($167 million), and Europe ($52 million) — and a market cap of approximately $10.2 billion, Vicor occupies a strategic bottleneck in AI hardware.

The growing demand for AI infrastructure has put enormous pressure on the power capacity of data centers. New AI chips consume amounts of energy that traditional electrical distribution systems were simply not designed to support efficiently. It is precisely at this bottleneck where Vicor finds its space, supplying high-efficiency power modules that feed high-consumption computing and automation platforms. Recent results show strong earnings momentum, a significantly larger order backlog, and upward revenue forecast revisions — signals that together suggest demand tied to building out AI computing capacity, not just purely speculative interest.

Tools we use daily

From an investor perspective, Vicor represents a bet on the growth of energy consumption tied to AI expansion. The risk, however, is there and deserves attention: the stock trades at an elevated price-to-earnings multiple, depends significantly on licensing revenues that tend to be volatile, and carries governance concerns following significant insider stock sales and limited board turnover. But the company’s position as a solution provider for a problem that is only going to get bigger — powering increasingly powerful data centers with growing efficiency — is a solid argument for those seeking exposure to AI infrastructure through less obvious and more fundamental paths, looking beyond the headlines about overworked software engineers. ⚡

What these stocks have in common and why it matters

Ouster, Insmed, and Vicor are very different companies in terms of sector, business model, and risk profile. But they all share a characteristic that puts them on the same map for investors thinking about AI infrastructure broadly: they solve real problems that the advancement of AI has created or intensified. Without quality sensing, physical automation does not scale. Without efficient power management, data centers cannot grow sustainably. Without advanced computational tools, drug discovery remains slow and expensive. Each of these companies attacks one of these limitations with specific and differentiated technology.

On top of that, the fact that none of them depends directly on the success of a single big tech company creates a more distributed risk profile. They have multiple clients, multiple markets, and value propositions that transcend any specific cycle of tech hype. This does not mean they are risk-free investments — far from it. All three present important points of concern, from operating losses to elevated multiples and insider stock sales. But it does mean that the rationale behind them is connected to long-term structural trends, not just the quarterly performance of some Silicon Valley giant. For investors seeking real portfolio productivity in a segment as dynamic as AI, understanding these less visible layers can be the difference between following the consensus and identifying where value is actually being built. 🎯

The AI infrastructure market is still far from reaching maturity. New use cases emerge constantly, demands for automation, energy efficiency, and computing capacity keep growing, and companies that already have validated technology and real customers hold an advantage over those still in the promise stage. Worth reinforcing that any analysis of this kind is general in nature and based on historical data and analyst projections, and does not constitute a buy or sell recommendation. Carefully evaluating what each of these companies delivers, the depth of their competitive advantage, and how they position themselves within the broader AI ecosystem is the most consistent path to making informed decisions in a sector where excitement often runs faster than fundamentals. 💡

Picture of Rafael

Rafael

Operations

I transform internal processes into delivery machines — ensuring that every Viral Method client receives premium service and real results.

Fill out the form and our team will contact you within 24 hours.

Related publications

Amazon's stock could rise following OpenAI partnership.

Amazon and OpenAI partnership could boost AI revenue and stock value, says Citi; strategic impact on AWS and infrastructure race.

Moratorium on AI Data Centers: Energy in Debate

Sanders and AOC propose moratorium on AI datacenter construction in the US to assess environmental and energy impacts.

Blockchain and AI Agents Are Changing Crypto Payments

AI agents power crypto payments with blockchain, stablecoins and x402, enabling autonomous transactions, micropayments and machine-to-machine economy

Receba o melhor conteúdo de inovação em seu e-mail

Todas as notícias, dicas, tendências e recursos que você procura entregues na sua caixa de entrada.

Ao assinar a newsletter, você concorda em receber comunicações da Método Viral. A gente se compromete a sempre proteger e respeitar sua privacidade.

Rafael

Online

Atendimento

Website Pricing Calculator

Find out how much the ideal website for your business costs

Website Pages

How many pages do you need?

Drag to select from 1 to 20 pages

In just 2 minutes, automatically find out how much a custom website for your business costs

More than 0+ companies have already calculated their quote

Fale com um consultor

Preencha o formulário e nossa equipe entrará em contato.